Sangamo Therapeutics
SGMO
SGMO
136 hedge funds and large institutions have $268M invested in Sangamo Therapeutics in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $289M → $268M (-$21.8M)
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
Holders
136
Holding in Top 10
1
Calls
$5.67M
Puts
$1.23M
Top Buyers
| 1 | +$8.12M | |
| 2 | +$3.76M | |
| 3 | +$2.4M | |
| 4 |
Millennium Management
New York
|
+$2.13M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.07M |
Top Sellers
| 1 | -$9.07M | |
| 2 | -$6.06M | |
| 3 | -$3.3M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$2.39M |
| 5 |
Renaissance Technologies
New York
|
-$2.26M |